Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EXCITE: Erbitux, Xeloda, Campto, Irradiation Then Excision for Locally Advanced Rectal Cancer (North West Clinical Oncology Group-04 on Behalf of the NCRI Rectal Cancer Subgroup)

NCT00972881 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT00972881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00972881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EXCITE: Erbitux, Xeloda, Campto, Irradiation Then Excision for Locally Advanced Rectal Cancer (North West Clinical Oncology Group-04 on Behalf of the NCRI Rectal Cancer Subgroup)
Lead sponsor
University College, London
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2009
Completion date
December 31, 2016
Enrollment
82 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer